Meduni Vienna: Skin infections can increase allergic inflammation in the lungs
A temporary bacterial infection of the skin can cause long-lasting changes in the immune system and increase allergic inflammation. This is the result of a study led by the Medical University of Vienna and the CeMM Research Center for Molecular Medicine, which has just been published in the leading journal "Science Immunology". The research reveals a previously unknown connection between the skin, bone marrow and lungs and promises the development of new treatment strategies for allergic diseases such as asthma.
The research team used a mouse model to investigate how a local bacterial infection influences the immune system. Staphylococcus aureus (S. aureus) is a common and widespread bacterium that can act as both a harmless skin inhabitant and a pathogen. The researchers found that in response to S. aureus skin infection, not only the expected immune cells (neutrophilic granulocytes), known for their role in fighting bacteria, migrated to the inflamed area. They also detected eosinophils, a special type of white blood cell that plays an important role in allergic diseases. Remarkably, the skin infection caused long-term changes in bone marrow stem cells from which eosinophils develop. "Our extensive analyses showed that the eosinophils from infected mice exhibited a long-lasting pro-inflammatory signature. This immune imprinting persisted long after the skin infection had resolved," reports first author Mariem Radhouani (MedUni Vienna's Department of Medicine I and CeMM).
Increased reaction to house dust mite allergens
To investigate the effects of this immunological reprogramming, the researchers exposed the previously infected mice to house dust mite allergens, which are the most common triggers of allergic asthma. "The results were astounding, but very clear: after contact with the allergens, animals with a previous skin infection developed more severe allergic inflammation in the lungs. They showed an increased number of eosinophils in the lung tissue, increased production of allergy-promoting antibodies and reduced lung function," explains study leader Philipp Starkl (MedUni Vienna's Department of Medicine I) the new findings. The researchers were also able to show that this enhanced immune response was mediated by the eosinophils originating from the altered bone marrow. Transplantation of eosinophils from previously infected mice to healthy animals was enough to cause increased allergic lung inflammation in the recipient mice.
The research team could identify two messenger substances that are crucial for this reprograming of eosiniophils: interleukin-33 (IL-33) and C5a, an important component of the complement system. As such, IL-33 promotes the proliferation of eosinophils in the bone marrow, while C5a directs the altered immune cells into the lungs. "Targeting these signalling pathways could represent a new treatment strategy for allergic diseases such as asthma or prevent their development," said the study authors, who are now planning further research to deepen and confirm the results.
Contact
Mag. Johannes Angerer
Medizinische Universität Wien
Leiter Kommunikation und Öffentlichkeitsarbeit
Telefon: 01/40160-11501
E-Mail: presse@meduniwien.ac.at
Website: https://www.meduniwien.ac.at/pr
Mag.a Karin Kirschbichler
Medizinische Universität Wien
Kommunikation und Öffentlichkeitsarbeit
Tel.: 01/ 40 160-11505
E-Mail: presse@meduniwien.ac.at
Website: https://www.meduniwien.ac.at/pr